OER by survival time for Cf-252, low dose rate Cs-137 and acute Co-60 for LSA lymphoma
Journal Article
·
· Nucl. Sci. Appl.; (United States)
OSTI ID:6698562
RBE and OER were determined for LSA tumor by survival time assay. The RBE/sub n/ of Cf vs. Cs-137 was 5.8 and the OER was --1.4 by experiments performed in vitro and assayed in vivo. When tumor was irradiated in an advanced state in the living mouse, the RBE/sub n/ was determined to be 5.2 vs. Cs-137. The RBE for hypoxic tumor is larger than for the oxic tumor for Cf-252 neutron irradiation.
- Research Organization:
- Radiation Medicine, Univ. of Kentucky Medical Center, Lexington, KY
- OSTI ID:
- 6698562
- Journal Information:
- Nucl. Sci. Appl.; (United States), Journal Name: Nucl. Sci. Appl.; (United States) Vol. 2:3; ISSN NSAPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Study of acute WCo, low dose rate CF-252 and CS-137 radiation on LSA ascites lymphoma in vivo
Response of lymphoid organs to low dose rate Cf-252, Cs-137 and acute Co-60
The response of mouse jejunal crypt cells to Cs-137 gamma rays and Cf-252 neutron irradiation
Journal Article
·
Thu Oct 31 23:00:00 EST 1985
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6333315
Response of lymphoid organs to low dose rate Cf-252, Cs-137 and acute Co-60
Journal Article
·
Tue Dec 31 23:00:00 EST 1985
· Nucl. Sci. Appl.; (United States)
·
OSTI ID:6716487
The response of mouse jejunal crypt cells to Cs-137 gamma rays and Cf-252 neutron irradiation
Journal Article
·
Tue Dec 31 23:00:00 EST 1985
· Nucl. Sci. Appl.; (United States)
·
OSTI ID:6695662
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ACTINIDE ISOTOPES
ACTINIDE NUCLEI
ALKALI METAL ISOTOPES
ALPHA DECAY RADIOISOTOPES
ANIMALS
ANOXIA
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOASSAY
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CALIFORNIUM 252
CALIFORNIUM ISOTOPES
CESIUM 137
CESIUM ISOTOPES
COBALT 60
COBALT ISOTOPES
DISEASES
EMISSION
EVEN-EVEN NUCLEI
HEAVY NUCLEI
IN VITRO
IN VIVO
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LOW DOSE IRRADIATION
LYMPHOMAS
MAMMALS
MEDICINE
MICE
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NEUTRON EMISSION
NEUTRON THERAPY
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
OXYGEN ENHANCEMENT RATIO
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RBE
RODENTS
SURVIVAL TIME
THERAPEUTIC USES
THERAPY
USES
VERTEBRATES
YEARS LIVING RADIOISOTOPES
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ACTINIDE ISOTOPES
ACTINIDE NUCLEI
ALKALI METAL ISOTOPES
ALPHA DECAY RADIOISOTOPES
ANIMALS
ANOXIA
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOASSAY
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CALIFORNIUM 252
CALIFORNIUM ISOTOPES
CESIUM 137
CESIUM ISOTOPES
COBALT 60
COBALT ISOTOPES
DISEASES
EMISSION
EVEN-EVEN NUCLEI
HEAVY NUCLEI
IN VITRO
IN VIVO
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LOW DOSE IRRADIATION
LYMPHOMAS
MAMMALS
MEDICINE
MICE
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NEUTRON EMISSION
NEUTRON THERAPY
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
OXYGEN ENHANCEMENT RATIO
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RBE
RODENTS
SURVIVAL TIME
THERAPEUTIC USES
THERAPY
USES
VERTEBRATES
YEARS LIVING RADIOISOTOPES